LEGEND CAPITAL
LEGEND CAPITAL is a Seed, Series A, Series B and Series C+ fund in the US, China and Southeast Asia writing $5M–$100M checks into Healthcare, tmt, healthcare-tech, consumer-brands, enterprise-services and intelligent-manufacturing.
- Stages
- Seed, Series A, Series B, Series C+
- Sectors
- Healthcare, tmt, healthcare-tech, consumer-brands, enterprise-services, intelligent-manufacturing
- Check size
- $5M–$100M
- Invests in
- US-wide, China, Southeast Asia
- Round role
- Leads and follows
- Actively investing
- Yes
- Founded
- 2001
- Assets under management
- $10B
- Website
- legendcapital.com.cn
Thesis
Legend Capital is a prominent Chinese venture capital and private equity firm founded in 2001, managing over $10 billion in AUM. They focus on early-stage and growth-stage investments primarily in China, Southeast Asia, and the US, targeting companies with strong unit economics and global expansion potential. Their core sectors include TMT, healthcare (biotech, medtech), consumer brands, enterprise services, and intelligent manufacturing. Legend Capital employs a strategy of both lead and follow investments, with check sizes ranging from $5 million to $100 million. They provide value-added services, leveraging their network and expertise, and integrate ESG considerations into their investment process, aligning with UN SDGs.
Common questions
Does LEGEND CAPITAL invest at the Seed stage?
Yes. LEGEND CAPITAL lists Seed, Series A, Series B and Series C+ among the stages it invests in.
What check size does LEGEND CAPITAL write?
LEGEND CAPITAL writes $5M–$100M checks.
Where does LEGEND CAPITAL invest?
LEGEND CAPITAL invests in the US, China and Southeast Asia.